191 related articles for article (PubMed ID: 33214406)
21. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
23. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
24. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
25. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
Aisenberg G; Rolston KV; Dickey BF; Kontoyiannis DP; Raad II; Safdar A
Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):13-20. PubMed ID: 17200840
[TBL] [Abstract][Full Text] [Related]
26. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.
Arthur C; Tang X; Romero JR; Gossett JG; Harik N; Prodhan P
Pediatr Cardiol; 2015 Mar; 36(3):509-15. PubMed ID: 25293429
[TBL] [Abstract][Full Text] [Related]
27. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Wang CH; Yu CM; Hsu ST; Wu RX
J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
[TBL] [Abstract][Full Text] [Related]
28. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
Sattler CA; Mason EO; Kaplan SL
Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infections in pediatric patients.
Babay HA; Twum-Danso K; Kambal AM; Al-Otaibi FE
Saudi Med J; 2005 Oct; 26(10):1555-61. PubMed ID: 16228055
[TBL] [Abstract][Full Text] [Related]
31. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.
Wang WS; Liu CP; Lee CM; Huang FY
J Microbiol Immunol Infect; 2004 Dec; 37(6):359-65. PubMed ID: 15599468
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study.
Sumida K; Chong Y; Miyake N; Akahoshi T; Yasuda M; Shimono N; Shimoda S; Maehara Y; Akashi K
PLoS One; 2015; 10(7):e0133731. PubMed ID: 26208218
[TBL] [Abstract][Full Text] [Related]
33. Stenotrophomonas maltophilia causing blood stream infection in neonates and infants: a cause for concern.
Sah R; Siwakoti S; Baral R; Rajbhandari RS; Khanal B
Trop Doct; 2018 Jul; 48(3):227-229. PubMed ID: 29161992
[TBL] [Abstract][Full Text] [Related]
34. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
35. The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004.
Jumaa PA; Sonnevend A; Pàl T; El Hag M; Amith R; Trad O
Ann Clin Microbiol Antimicrob; 2006 Dec; 5():32. PubMed ID: 17194302
[TBL] [Abstract][Full Text] [Related]
36. Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.
Ebara H; Hagiya H; Haruki Y; Kondo E; Otsuka F
Intern Med; 2017; 56(2):137-142. PubMed ID: 28090041
[TBL] [Abstract][Full Text] [Related]
37. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.
Friedman ND; Korman TM; Fairley CK; Franklin JC; Spelman DW
J Infect; 2002 Jul; 45(1):47-53. PubMed ID: 12217732
[TBL] [Abstract][Full Text] [Related]
38. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
Mori M; Tsunemine H; Imada K; Ito K; Kodaka T; Takahashi T
Ann Hematol; 2014 Jun; 93(6):901-11. PubMed ID: 24535696
[TBL] [Abstract][Full Text] [Related]
39. Gram-negative bacterial infections in surgical intensive care unit patients following abdominal surgery: high mortality associated with Stenotrophomonas maltophilia infection.
Lin TL; Chang PH; Liu YW; Lai WH; Chen YJ; Chen IL; Li WF; Wang CC; Lee IK
Antimicrob Resist Infect Control; 2024 Jun; 13(1):65. PubMed ID: 38886759
[TBL] [Abstract][Full Text] [Related]
40. Stenotrophomonas maltophilia bacteremia in burn patients.
Tsai WP; Chen CL; Ko WC; Pan SC
Burns; 2006 Mar; 32(2):155-8. PubMed ID: 16448762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
